Warming Centers for the Metro St. Louis Area
Closings: Schools, churches, day-cares and businesses

New drug developed at SLU hospital shows promise in fighting heart disease

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

ST. LOUIS (KPLR) – Cardiovascular disease is the leading cause of death worldwide, but new drugs called PCSK9 inhibitors appear to be a step in reversing that trend.

Dr. Michael Lim, Director of Cardiology at SSM Health Saint Louis University Hospital, is referring to the cardiovascular drug Repatha. Dr. Lim said a study on the drug released late last week had some amazing results.

"They reduce their LDL or bad cholesterol another 60 percent. The first year, about 16 percent decreased risk of heart attacks or stroke. The second year, a total of about 33 percent decrease in heart attacks or stroke,” he said.

Cardiovascular disease remains the number one health burden in the world; but doctor Lim is hopeful drugs like this along with a healthy lifestyle could change that.

Dr. Lim notes these drugs aren't for everyone and can be quite costly.

Google Map for coordinates 38.623120 by -90.239342.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.